期刊文献+

Association of MPO gene polymorphism with coronary artery injury and therapeutic effect of IVIG combined with heparin in children with KD

在线阅读 下载PDF
导出
摘要 Objective: To investigate the relationship between the polymorphism of myeloperoxidase (MPO) gene and coronary artery injury in children with Kawasaki disease (KD) and the therapeutic effect of human immunoglobulin (IVIG) combined with heparin. Methods: A total of 78 KD children and 65 normal children treated in our hospital from April 2016 to February 2018 were selected as the s study ubjects. They were divided into coronary artery injury group (36 cases) and non-coronary artery injury group (42 cases) according to whether or not coronary artery injury occurred. Polymerase chain-endonuclease fragment (PCR-RFLP) was used to determine the distribution of single nucleotide polymorphism (SNP) locus polymorphism of MPO gene. Clinical data of children were collected to compare the distribution of genotype frequency and allele frequency among different groups. All KD children were treated with IVIG combined with low molecular weight heparin calcium subcutaneously. The correlation between MPO gene polymorphism and therapeutic effect was analyzed. Results: The frequencies of three genotypes (AA, AG and GG) in KD group were 1.28%, 20.51% and 78.21% respectively, while those in control group were 9.23%, 63.08% and 23.08% respectively. There was a significant difference between the two groups;the allele frequency of G in KD group was 88.46%, significantly higher than 76.92% in control group. The frequency distribution of each genotype in coronary artery injury group was significantly different from that in non-coronary artery injury group. The frequency of G allele in coronary artery injury group was significantly higher than that in non-coronary artery injury group. The total effective rate of KD group was 75.64%. The total effective rate of AG+AA genotype and GG genotype was 94.12% and 70.49%, respectively. The difference was statistically significant. There was no significant difference in coronary artery diameter between different genotypes before treatment, and after treatment, the GA+AA genotype's coronary artery diameter was significantly reduced compared with GG genotype's;the total fever time, the time of congestion and edema subsidence, the time of lymphadenopathy subsidence in GA+AA genotype were significantly shorter and those in the GG genotype. Conclusion: The SNP polymorphism of MPO gene may be related to the occurrence of coronary artery injury in children with KD, and G allele may be a risk factor. In addition, the polymorphism of MPO gene is associated with the efficacy of IVIG combined with heparin in the treatment of KD, which may be an effective predictor of the efficacy of IVIG combined with heparin.
出处 《Journal of Hainan Medical University》 2019年第7期38-42,共5页 海南医学院学报(英文版)
作者简介 Corresponding author:Zong-Xiu Zhao,Chengdu Women's and Children's Central Hospital,Chendu 610031.Email:2466181092@.qq.com
  • 相关文献

参考文献3

二级参考文献21

  • 1胡亚美,江载芳.诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2012:698-700.
  • 2Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment and long-term management of Kawasaki disease: a statement for health professionals from the committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young [J]. American Heart Association. Pediatrics, 2004, 114(6) : 1708.
  • 3Yanagawa H, Sonobe T. Changes in the diagnostic guidelines for Kawasaki disease In: Yanagawa H, Nakamuru Y, Yashiro M, et al. Epidemi-ology of Kawasaki disease : A30-year achievement [ J ]. Tokyo : Shindan To Chiryosha, 2004,24.
  • 4Bums JC, Herzog L, Fabri O, et al. Seasonality of Kawasaki disease : a global perspective [ J ]. Plos one, 2013,8 (9) : e74529.
  • 5Mori M, Imagawa T, Yasui K, et al. Predictors of coronary artery lesions after intravenous gamma - globulin treatment in Kawasaki disease [J]. J Padiatr, 2000, 137(2) : 177.
  • 6Oki I, Tanihara S, Ojima T, et al. A multicenter collaborative study on the risk factors of cardiac sequelae due to Kawasaki disease: a one-year follow- up study [ J ]. Acts Paediatr, 2000,89 (12) : 1435.
  • 7赵丽丽,王一彪,索琳.中国川崎病患儿并发冠状动脉病变高危因素的Meta分析[J].中华儿科杂志,2011,49(6):459-467. 被引量:25
  • 8王华平.不同剂量的注射用丙种球蛋白治疗川崎病的临床疗效及对血清炎性细胞因子的影响[J].中国医师进修杂志,2014,37(3):50-52. 被引量:18
  • 9杨波,罗军,张颖,张召艳.川崎病治疗新进展[J].中华实用儿科临床杂志,2014,29(9):707-709. 被引量:19
  • 10郭伟,方俊梅.血浆脑利钠肽在不完全型川崎病患儿诊断中的临床意义[J].中华危重症医学杂志(电子版),2014,7(3):43-45. 被引量:7

共引文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部